Sevinc Mustafa, Hasbal Nuri Baris, Ozcelik Gul, Akinci Nurver, Basturk Taner, Koc Yener, Kirecci Sinan Levent, Demir Mesut, Dokucu Ali Ihsan, Unsal Abdulkadir
Nephrology Department, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Nephrology Department, Hakkari State Hospital, Hakkari, Turkey.
Transplant Proc. 2019 Sep;51(7):2279-2282. doi: 10.1016/j.transproceed.2019.01.194. Epub 2019 Jul 26.
Approximately 6.3 million Syrian people migrated to other countries due to war since 2011. There are more than 3.5 million Syrian people living in Turkey under temporary protection. Syrian people receive free health care in Turkey, including kidney transplantation. Our institution started a kidney transplantation program about 3 years ago. It is the first institution performing living, related kidney transplantation for Syrian patients with end-stage renal failure.
All living, related kidney transplantations to Turkish and Syrian patients from the beginning of our transplantation program until September 2018 were enrolled in this study. Donor and recipient characteristics, induction and maintenance immunosuppression, length of hospital stay, creatinine values at first week and first month, treatment incompatibility, and graft survival were evaluated.
Of the 25 living, related kidney transplantations 20% were Syrian. Three of 5 Syrian recipients were in the pediatric age group. None of the Syrian transplantations were preemptive, while half of the Turkish transplantations were preemptive (P = .005). Immunosuppression protocols, creatinine values, length of hospital stay, and graft survival rates were similar between groups. None of the Syrian recipients had treatment incompatibility (0%), unlike the Turkish recipients (15%).
Outcomes of kidney transplantation for Syrian recipients are similar to those of Turkish recipients. Having this no-cost facility is great for Syrian kidney failure patients. The number of transplantations for Syrian patients under temporary protection in Turkey is expected to increase in the future, with these favorable results and easy to access, free health care facilities.
自2011年以来，约630万叙利亚人因战争移民到其他国家。超过350万叙利亚人在土耳其获得临时保护。叙利亚人在土耳其可享受免费医疗，包括肾脏移植。我们机构大约在3年前启动了肾脏移植项目。这是首个为终末期肾衰竭的叙利亚患者进行亲属活体肾脏移植的机构。
纳入从我们的移植项目开始至2018年9月期间所有为土耳其和叙利亚患者进行的亲属活体肾脏移植。评估供体和受体特征、诱导和维持免疫抑制、住院时间、第一周和第一个月的肌酐值、治疗不相容性及移植物存活率。
在25例亲属活体肾脏移植中，20%为叙利亚患者。5例叙利亚受体中有3例为儿童年龄组。叙利亚患者的移植均非抢先移植，而土耳其患者移植的一半为抢先移植（P = .005）。两组间免疫抑制方案、肌酐值、住院时间及移植物存活率相似。叙利亚受体均无治疗不相容情况（0%），而土耳其受体为15%。
叙利亚受体的肾脏移植结果与土耳其受体相似。拥有这种免费医疗设施对叙利亚肾衰竭患者来说非常好。鉴于这些良好结果以及易于获得的免费医疗设施，预计未来在土耳其获得临时保护的叙利亚患者的移植数量将会增加。
